John Theurer Cancer Center
Hackensack Meridian HealthJohn Theurer Cancer Center
1 of only 16 cancer center consortia in the U.S. approved by the National Cancer Institute.Learn More
Ready to Re-Write Cancer
John Theurer Cancer Center, part of Hackensack University Medical Center, is New Jersey’s largest and most comprehensive cancer program. In less than 25 years, we’ve become one of the most prominent programs nationwide, with more than 1,200 team members collaborating in a highly subspecialized and multidisciplinary environment. Not surprisingly, more people in the New Jersey/New York metropolitan area turn to John Theurer Cancer Center for cancer care each year than to any other facility in New Jersey.
With CAR T-cell therapy, immune cells called T cells are:
- Removed from the patient through a process called “apheresis” (the separation of T cells from other components of the blood)
- Genetically modified, using a disarmed virus, to produce receptors on their surfaces called CARs, allowing the T cells to recognize and attach to certain targets on cancer cells
- Grown to larger quantities (hundreds of millions)
- Returned to the patient, where the CAR T cells can now find, bind to, and kill cancer cells
For more information please call 551-996-5931.
Teaming Up to Take on Cancer
John Theurer Cancer Center. Georgetown Lombardi Comprehensive Cancer Center. Two strong institutions that share a passion and expertise for developing new therapies to improve outcomes for patients with cancer.Joining Forces
The largest clinical research team in New Jersey.Research at John Theurer Cancer Center
For More Information
Call us to speak with a member of our team.Call 551-996-5855
You may also be interested in
The Research Division consolidates the basic and translational research and clinical trials that are conducted at John Theurer Cancer Center and the David Joseph Jurist Research Center for Tomorrows Children.
The BMT program, which offers both autologous and donor stem cell transplantations, has consistently been awarded highest grades by FACT accreditation for 25 years.
Our patients have access to tomorrow’s cancer medicines including new agents which can offer successful alternatives to chemotherapy. The depth and breadth of experience of our world class experts, who each focus on specific subtypes of cancer, results in the best available personalized care.